Inflammatory Mediators in Diabetic Neuropathy

被引：25

作者：

Wilson, Natalie M. ^{[1
]}

Wright, Douglas E. ^{[1
]}

机构：

[1] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66160 USA

来源：

JOURNAL OF DIABETES & METABOLISM | 2012年 / 3卷

关键词：

D O I：

10.4172/2155-6156.S5-004

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Diabetic neuropathy (DN) is the most common complication of diabetes mellitus, resulting in high health care costs and greatly affecting the quality of life of patients. The mechanism(s) responsible for the development of DN is currently unclear, but is likely multifactoral. While a great deal is still unknown about the mediators responsible for the development of DN, current knowledge of other neuropathic conditions suggest the involvement of a number of inflammatory mediators such as interleukins and chemokines. This review will outline the current literature of a number of inflammatory mediators in both human and rodent studies. As there is currently no therapeutic treatment for DN, this review will also provide an overview of therapeutics targeting inflammation and the ability of these therapies to improve the symptoms of DN.

引用

页数：6

共 42 条

[1] Cytokines as a precipitant of depressive illness: Animal and human studies [J].

Anisman, H ;

Merali, Z ;

Poulter, MO ;

Hayley, S .

CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (08) :963-972

[2] TLR4 mutations are associated with endotoxin hyporesponsiveness in humans [J].

Arbour, NC ;

Lorenz, E ;

Schutte, BC ;

Zabner, J ;

Kline, JN ;

Jones, M ;

Frees, K ;

Watt, JL ;

Schwartz, DA .

NATURE GENETICS, 2000, 25 (02) :187-+

[3] Diabetes-associated sustained activation of the transcription factor nuclear factor-κB [J].

Bierhaus, A ;

Schiekofer, S ;

Schwaninger, M ;

Andrassy, M ;

Humpert, PM ;

Chen, J ;

Hong, M ;

Luther, T ;

Henle, T ;

Klöting, I ;

Morcos, M ;

Hofmann, M ;

Tritschler, H ;

Weigle, B ;

Kasper, M ;

Smith, M ;

Perry, G ;

Schmidt, AM ;

Stern, DM ;

Häring, HU ;

Schleicher, E ;

Nawroth, PP .

DIABETES, 2001, 50 (12) :2792-2808

[4] Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily [J].

Bierhaus, A ;

Haslbeck, KM ;

Humpert, PM ;

Liliensiek, B ;

Dehmer, T ;

Morcos, M ;

Sayed, AAR ;

Andrassy, M ;

Schiekofer, S ;

Schneider, JG ;

Schulz, JB ;

Heuss, D ;

Neundörfer, B ;

Dierl, S ;

Huber, J ;

Tritschler, H ;

Schmidt, AM ;

Schwaninger, M ;

Haering, HU ;

Schleicher, E ;

Kasper, M ;

Stern, DM ;

Arnold, B ;

Nawroth, PP .

JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (12) :1741-1751

[5] EFFICACY AND SAFETY OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS IN THE THERAPY OF DIABETIC NEUROPATHY [J].

COHEN, KL ;

HARRIS, S .

ARCHIVES OF INTERNAL MEDICINE, 1987, 147 (08) :1442-1444

[6] High Glucose Induces Toll-Like Receptor Expression in Human Monocytes Mechanism of Activation [J].

Dasu, Mohan R. ;

Devaraj, Sridevi ;

Zhao, Ling ;

Hwang, Daniel H. ;

Jialal, Ishwarlal .

DIABETES, 2008, 57 (11) :3090-3098

[7] Increased levels of ligands of Toll-like receptors 2 and 4 in type 1 diabetes [J].

Devaraj, S. ;

Dasu, M. R. ;

Park, S. H. ;

Jialal, I. .

DIABETOLOGIA, 2009, 52 (08) :1665-1668

[8] Increased toll-like receptor (TLR)2 and TLR4 expression in monocytes from patients with type 1 diabetes: Further evidence of a proinflammatory state [J].

Devaraj, Sridevi ;

Dasu, Mohan R. ;

Rockwood, Jason ;

Winter, William ;

Griffen, Steven C. ;

Jialal, Ishwarlal .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (02) :578-583

[9] Microvascular Reactivity and Inflammatory Cytokines in Painful and Painless Peripheral Diabetic Neuropathy [J].

Doupis, John ;

Lyons, Thomas E. ;

Wu, Szuhuei ;

Gnardellis, Charalambos ;

Dinh, Thanh ;

Veves, Aristidis .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (06) :2157-2163

[10] TNF-alpha expression in painful and nonpainful neuropathies [J].

Empl, M ;

Renaud, S ;

Erne, B ;

Fuhr, P ;

Straube, A ;

Schaeren-Wiemers, N ;

Steck, AJ .

NEUROLOGY, 2001, 56 (10) :1371-1377

← 1 2 3 4 5 →